MetaImmuneTech Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$327K
- Investors
-
5
MetaImmuneTech General Information
Description
Developer of a digital cell analysis platform designed to enable rapid, label-free analysis of immune cells for diagnostics, immune monitoring, and cell therapy development. The company offers proprietary Lens-free Shadow Imaging Technology and the Cellytics platform for analyzing immune cell count, morphology, and function, enabling researchers and healthcare organizations to assess immune cells without labeling.
Contact Information
Website
metaimmunetech.krCorporate Office
- 2511, 310/509/508 Industry-Academic Cooperation Center
- Sejong-ro
- Sejong, Sejong 30019
- South Korea
Corporate Office
- 2511, 310/509/508 Industry-Academic Cooperation Center
- Sejong-ro
- Sejong, Sejong 30019
- South Korea
MetaImmuneTech Timeline
MetaImmuneTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 03-Jul-2026 | $327K | Completed | Generating Revenue | ||
| 6. Seed Round | 04-Dec-2025 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 20-Jun-2024 | Completed | Generating Revenue | |||
| 4. Seed Round | 13-Oct-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Apr-2024 | Completed | Generating Revenue | |||
| 2. Seed Round | 25-Apr-2022 | $81.5K | $81.5K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MetaImmuneTech Patents
MetaImmuneTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026177331-A1 | Method, device and kit for analyzing immune cells for companion animals | Pending | 20-Feb-2025 | ||
| WO-2026054439-A1 | Device and method for diagnosing infectious disease using lens-free shadow imaging technology based on t cell response | Pending | 03-Sep-2024 | ||
| US-12770257-B2 | Apparatus for analyzing natural killer cell activity using lens-free shadow imaging technique, and method therefor | Active | 17-Sep-2021 | ||
| US-20250131557-A1 | Apparatus for analyzing natural killer cell activity using lens-free shadow imaging technique, and method therefor | Active | 17-Sep-2021 | ||
| WO-2023042999-A1 | Apparatus for analyzing natural killer cell activity using lens-free shadow imaging technique, and method therefor | Inactive | 17-Sep-2021 | G06T7/0012 |
MetaImmuneTech Signals
MetaImmuneTech Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boditech Med | Corporation | Minority | ||
| Vaxcell-Bio Therapeutics | Corporation | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | |||
| Korea University Holdings | Accelerator/Incubator | Minority | ||
| KU Startup | Accelerator/Incubator |
MetaImmuneTech FAQs
-
When was MetaImmuneTech founded?
MetaImmuneTech was founded in 2020.
-
Where is MetaImmuneTech headquartered?
MetaImmuneTech is headquartered in Sejong, South Korea.
-
What is the size of MetaImmuneTech?
MetaImmuneTech has 6 total employees.
-
What industry is MetaImmuneTech in?
MetaImmuneTech’s primary industry is Diagnostic Equipment.
-
Is MetaImmuneTech a private or public company?
MetaImmuneTech is a Private company.
-
What is the current valuation of MetaImmuneTech?
The current valuation of MetaImmuneTech is .
-
What is MetaImmuneTech’s current revenue?
The current revenue for MetaImmuneTech is .
-
How much funding has MetaImmuneTech raised over time?
MetaImmuneTech has raised $1.21M.
-
Who are MetaImmuneTech’s investors?
Boditech Med, Vaxcell-Bio Therapeutics, Tech Incubator Program for Startup, Korea University Holdings, and KU Startup have invested in MetaImmuneTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process